This article is more than 5 years old. Information may no longer be current.
Center names chief of neuro-oncology
Click Here to Manage Email Alerts
Howard A. Fine, MD, has been selected to lead the newly established neuro-oncology program at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Fine will serve as director of the Brain Tumor Center and associate director for translational research in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College. He also will serve as chief of the division of neuro-oncology at NewYork-Presbyterian/Weill Cornell.
“As part of the Meyer Cancer Center, the Weill Cornell Brain Tumor Center at NewYork-Presbyterian Hospital will offer its patients the highest level of comprehensive state-of-the-art care delivered by nationally renowned clinical experts from multiple disciplines,” Fine said in a press release. “With this level of world-class clinical and scientific expertise, along with an institutional commitment to the vision of a better future for patients suffering with brain tumors, NewYork-Presbyterian/Weill Cornell is uniquely positioned to make a huge impact on the field by providing innovative and highly effective treatments for patients with brain tumors.”
Howard A. Fine
Fine most recently served as deputy director of the cancer center and director of the Brain Tumor Center at NYU Langone. He previously served as director of the Neuro-Oncology Disease Center at Dana-Farber Cancer Institute and the neuro-oncology program at Dana-Farber/Harvard Cancer Center. He also served as chief of the Neuro-Oncology Branch at the NIH.
“The recruitment of Dr. Howard Fine will be transformational for the department of neurology and the clinical neuroscience programs at NewYork-Presbyterian Hospital and Weill Cornell Medical College,” Matthew E. Fink, MD, neurologist-in-chief at NewYork-Presbyterian/Weill Cornell and the Louis and Gertrude Feil professor and chairman of the department of neurology at Weill Cornell Medical College, said in a press release. “He brings knowledge and expertise to a specialized area that we have not pursued in the past, and he will help a key program, the Brain Tumor Center of the Meyer Cancer Center, fulfill its mission and vision.”